Efficacy and safety of imatinib in CML over 10 years.

Abstract Poster

Authors

null

Rüdiger Hehlmann

III. Medizinische Universitätsklinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany

Rüdiger Hehlmann , Lida Kalmanti , Christian Dietz , Michael Lauseker , Lisa Heinrich , Ulrike Proetel , Andreas Hochhaus , Martin C. Müller , Alice Fabarius , Stefan W. Krause , Jolanta Dengler , Christiane Falge , Gabriela M. Baerlocher , Lothar Kanz , Frank Stegelmann , Michael Pfreundschuh , Karsten Spiekermann , Markus Pfirrmann , Susanne Saussele , Joerg Hasford

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Highlights Session

Session Title

Leukemia, Myelodysplasia, and Transplantation

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Leukemia

Clinical Trial Registration Number

NCT00055874

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 7021)

DOI

10.1200/jco.2014.32.15_suppl.7021

Abstract #

7021

Poster Bd #

13

Abstract Disclosures

Similar Posters

First Author: Ruediger Hehlmann

First Author: Jeffrey H. Lipton

First Author: Rüdiger Hehlmann

First Author: Simona Soverini